Evidence map›Paper›PMID 26086192›Full record

ReviewPLoS pathogens2015

Targeting Human Transmission Biology for Malaria Elimination.

Sandra K Nilsson, Lauren M Childs, Caroline Buckee, Matthias Marti

Open access · goldAbstract readReview
In one paragraph

Review in PLoS pathogens, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 55 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
55citing papers in PubMed, 1 pooled it
14.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

55 citing papers in PubMed, 1 synthesis or guideline pooled it, 107 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Article
  5. Review
  6. Article
  7. Article
  8. Experimental biology and medicine (Maywood, N.J.) · 2023
    Review
  9. Microorganisms · 2023
    Review
  10. Review
  11. Article
  12. Regulation of phosphoinositide metabolism in Apicomplexan parasites.Frontiers in cell and developmental biology · 2023
    Review
  13. Article
  14. Targeting theHeliyon · 2022
    Review
  15. Adapt or Die: Targeting Unique Transmission-Stage Biology for Malaria Elimination.Frontiers in cellular and infection microbiology · 2022
    Review
  16. Review
  17. Review
  18. Article
  19. Article
  20. Progress towards the development of aExpert review of vaccines · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Sandra K NilssonDepartment of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, United States of America.
Lauren M ChildsCentre for Communicable Disease Dynamics and Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, United States of America.
Caroline BuckeeCentre for Communicable Disease Dynamics and Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, United States of America.
Matthias MartiDepartment of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, United States of America.
Center for Disease Dynamics, Economics & Policy · USHarvard University · US

Funding

Understanding and controlling antibiotic resistanceU54GM088558 · NIGMS · HARVARD SCHOOL OF PUBLIC HEALTH · PI NOBLES, FELISA · 2009 to 2018
$26.4M
Cytoadherence and sequestration in malaria transmission stagesR01AI077558 · NIAID · HARVARD SCHOOL OF PUBLIC HEALTH · PI MARTI, MATTHIAS · 2010 to 2013
$1.6M
A forward genetic screen to identify determinants of malaria stage conversionR21AI105328 · NIAID · HARVARD SCHOOL OF PUBLIC HEALTH · PI MARTI, MATTHIAS · 2013 to 2014
$443k
NIAID NIH HHS 1R21AI105328NIAID NIH HHS 5R01AI077558NIAID NIH HHS R01 AI077558NIAID NIH HHS R21 AI105328NIGMS NIH HHS U54 GM088558NIGMS NIH HHS U54GM088558
6 · The paper itself

Abstract

Malaria remains one of the leading causes of death worldwide, despite decades of public health efforts. The recent commitment by many endemic countries to eliminate malaria marks a shift away from programs aimed at controlling disease burden towards one that emphasizes reducing transmission of the most virulent human malaria parasite, Plasmodium falciparum. Gametocytes, the only developmental stage of malaria parasites able to infect mosquitoes, have remained understudied, as they occur in low numbers, do not cause disease, and are difficult to detect in vivo by conventional methods. Here, we review the transmission biology of P. falciparum gametocytes, featuring important recent discoveries of genes affecting parasite commitment to gametocyte formation, microvesicles enabling parasites to communicate with each other, and the anatomical site where immature gametocytes develop. We propose potential parasite targets for future intervention and highlight remaining knowledge gaps.

Indexed as

AnimalsCulicidaeHumansLife Cycle StagesMalaria, FalciparumPlasmodium falciparum

Identifiers

PMID26086192
PMCPMC4472755
OpenAlexW920975095

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.